Critical Reviews in Oncology / Hematology
Volume 78, Issue 2 , Pages 150-161 , May 2011

Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes

  • J. Loeffler-Ragg

      Affiliations

    • Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • U. Germing

      Affiliations

    • Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
  • ,
  • W.R. Sperr

      Affiliations

    • Department of Internal Medicine I, Division of Hematology and Hemostaseology, Vienna Medical University, Vienna, Austria
  • ,
  • H. Herrmann

      Affiliations

    • Ludwig Boltzmann Cluster Oncology, Vienna, Austria
  • ,
  • H. Zwierzina

      Affiliations

    • Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • P. Valent

      Affiliations

    • Department of Internal Medicine I, Division of Hematology and Hemostaseology, Vienna Medical University, Vienna, Austria
    • Ludwig Boltzmann Cluster Oncology, Vienna, Austria
  • ,
  • H. Ulmer

      Affiliations

    • Department of Biostatistics and Documentation, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • R. Stauder

      Affiliations

    • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 512 504 23255.

,Accepted 28 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(10)00140-X

doi: 10.1016/j.critrevonc.2010.05.008

Critical Reviews in Oncology / Hematology
Volume 78, Issue 2 , Pages 150-161 , May 2011